Quetiapine and rivastigmine for agitation in Alzheimer’s disease

被引：1
|
作者：
Raymond L. Ownby
机构：
来源：
Current Psychiatry Reports | 2006年 / 8卷 / 1期
关键词：
Cognitive Decline; Cholinesterase; Quetiapine; Rofecoxib; Rivastigmine;
D O I：
10.1007/s11920-006-0075-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [21] Rivastigmine: An acetylcholinesterase inhibitor for patients with Alzheimer's disease
    White, CM
    Dicks, RS
    FORMULARY, 1999, 34 (06) : 493 - +
  • [22] Rivastigmine - A review of its use in Alzheimer's disease
    Spencer, CM
    Noble, S
    DRUGS & AGING, 1998, 13 (05) : 391 - 411
  • [23] Disentangling the Treatment of Agitation in Alzheimer's Disease
    Howard, Robert J.
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (05): : 441 - 443
  • [24] Donepezil for the treatment of agitation in Alzheimer's disease
    Howard, Robert J.
    Juszczak, Edmund
    Ballard, Clive G.
    Bentham, Peter
    Brown, Richard G.
    Bullock, Roger
    Burns, Alistair S.
    Holmes, Clive
    Jacoby, Robin
    Johnson, Tony
    Knapp, Martin
    Lindesay, James
    O'Brien, John T.
    Wilcock, Gordon
    Katona, Cornelius
    Jones, Roy W.
    DeCesare, Julia
    Rodger, Michaela
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (14): : 1382 - 1392
  • [25] Advancements in the treatment of agitation in Alzheimer's disease
    Antonsdottir, Inga M.
    Smith, Jessica
    Keltz, Melanie
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (11) : 1649 - 1656
  • [26] Commentary on "Cannabinoids for Agitation in Alzheimer's Disease"
    Goveas, Joseph S.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (12): : 1264 - 1266
  • [27] Pharmacologic management of agitation in Alzheimer's disease
    Profenno, LA
    Tariot, PN
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) : 65 - 77
  • [28] Agitation and aggression in people with Alzheimer's disease
    Ballard, Clive
    Corbett, Anne
    CURRENT OPINION IN PSYCHIATRY, 2013, 26 (03) : 252 - 259
  • [29] Gabapentin for behavioral agitation in Alzheimer's disease
    Regan, WM
    Gordon, SM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (01) : 59 - 60
  • [30] Slow dose escalation of rivastigmine (Exelon®) treatment of agitation in patients with Alzheimer's disease:: An eight-month prospective study
    Shua-Haim, J
    Smith, J
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S73 - S73
12345